OPEN The New England journal of medicine | 6 Nov 2012
GM Chertow, GA Block, R Correa-Rotter, TB Drüeke, J Floege, WG Goodman, CA Herzog, Y Kubo, GM London, KW Mahaffey, TC Mix, SM Moe, ML Trotman, DC Wheeler and PS Parfrey
Disorders of mineral metabolism, including secondary hyperparathyroidism, are thought to contribute to extraskeletal (including vascular) calcification among patients with chronic kidney disease. It has been hypothesized that treatment with the calcimimetic agent cinacalcet might reduce the risk of death or nonfatal cardiovascular events in such patients.
* Data courtesy of Altmetric.com